ABCB1/MDR1 gene polymorphism and colorectal cancer risk: A meta-analysis of case-control studies

Colorectal Disease

Volumn 15, Issue 1, 2013, Pages 12-18

  He, T ^a   Mo, A ^a   Zhang, K ^a   Liu, L ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

ABCB1; Colorectal cancer; Meta analysis; Multidrug resistance 1; Polymorphism

Indexed keywords

MARKER; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; DNA POLYMORPHISM; ETHNICITY; GENE EXPRESSION; GENE FREQUENCY; HAPLOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; WILD TYPE;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; ODDS RATIO; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84871644866     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.02919.x     Document Type: Article

References (29)

1. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-32.
2. Huxley RR, Ansary-Moghaddam A, Clifton P. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009; 125: 71-80.
3. Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 2001; 1: 189-99.
4. Cascorbi I. Role of pharmacogenetics of ATP-binding cassette transporters in the pharma-cokinetics of drugs. Pharmacol Ther 2006; 112: 457-73.
5. Kimchi-Sarfaty C, Oh JM, Kim IW et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315: 525-52.
6. Hoffmeyer S, Burk O, Von Richter O et al. Functional polymorphisms of the human multidrug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci 2000; 97: 3473-8.
7. Cascorbi I, Gerloff T, Johne A et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001; 69: 169-74.
8. Siegsmund M, Brinkmann U, Schaffeler E et al. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 2002; 13: 1847-54.
9. Jamroziak K, Młynarski W, Balcerczak E et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 2004; 72: 314-21.
10. Miller KL, Kelsey KT, Wiencke JK et al. The C3435T polymorphism of MDR1 and susceptibility to adult glioma. Neuroepidemiology 2005; 25: 85-90.
11. Pei-Hua L, Mu-Xin W, Jie Y et al. Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat 2011; 125: 537-43.
12. Andersen V, Agerstjerne L, Jensen D et al. The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study. BMC Medical Genetics 2009; 10: 1-6.
13. Andersen V, Stergaard M, Christensen J et al. Polymorphisms in the xenobiotic transporter Multidrug Resistance1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer 2009; 9: 1-11.
14. Komoto C, Nakamura T, Sakaeda T et al. MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer. Drug Metab Pharmacokinet 2006; 21: 126-32.
15. Osswald E, Johne A, Laschinski G et al. Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers. Eur J Clin Pharmacol 2007; 63: 9-16.
16. Panczyk M, Balcerczak E, Piaskowski S et al. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer. Int J Colorectal Dis 2009; 24: 895-905.
17. Petrova DT, Nedeva P, Maslyankovl S et al. No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients. J Cancer Res Clin Oncol 2008; 134: 317-22.
18. Bae SY, Choi SK, Kim KR et al. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci 2006; 97: 774-9.
19. Fung KL, Gottesman MM. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta 2009; 1794: 860-71.
20. Gervasini G, Carrillo JA, Garcia M et al. ABCB1/ (Multidrug Resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer. Cancer 2006; 107: 2850-7.
21. Wang HJ, Jin GF, Wang HF et al. Genetic susceptibility of lung cancer associated with common variants in the 30 untranslated regions of ABCB1 and ABCC1 candidate transporter genes for carcinogen export. Cancer 2009; 115: 595-607.
22. Jamroziak K, Balcerczak E, Smolewski P et al. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Pharmacological Reports 2006; 58: 720-8.
23. Sama SS, Thomasa V, Sivagnanama K et al. ABCB1 genetic polymorphism and risk of upper aerodigestive tract cancers among smokers, tobacco chewers and alcoholics in an Indian population. Pharmacogenet Genomics 2007; 17: 861-6.
24. Sabahi Z, Salek R, Heravi RE et al. Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian J Cancer 2010; 47: 317-21.
25. Gaikovitch E, Mrozikievicz P, Wagner F, Roots I. Association of C3435T and G2677T/A polymorphisms of multidrug resistance gene with colorectal cancer risk. Clin Pharmacol Ther 2004; 75: 17.
26. Khedri A, Nejat-Shokouhi A, Salek R et al. Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population. Mol Biol Rep 2011; 38: 2939-43.
27. Kurzawski M, Drozdzik M, Suchy J et al. Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol 2005; 61: 389-94.
28. Bo-In L, Kyu-Yong C, Kang-Moon L et al. Is C3435T polymorphism of MDR1 related to inflammatory bowel disease or colorectal cancer in Korean?Korean J Gastroenterol 2006; 47: 22-9.
29. Sainz J, Rudolph A, Hein R et al. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. Endocr Relat Cancer 2011; 18: 265-76.